HYDROFARM HOLDINGS GROUP, INC. quarterly report, Q3 FY2021

Hydrofarm Holdings Group, Inc. — Q3 2021 Form 10-Q

Reporting period: Three and nine months ended September 30, 2021. Hydrofarm distributes and manufactures controlled-environment agriculture equipment and supplies, primarily in the U.S. and Canada. Financial amounts below are in U.S. dollars; millions are rounded.

Financial performance

MetricQ3 2021Q3 2020Nine months 2021Nine months 2020
Net sales$123.8m$96.7m$369.0m$254.8m
Gross profit / margin$30.0m / 24.2%$18.2m / 18.8%$82.8m / 22.4%$47.6m / 18.7%
Operating income (loss)($2.4m)$5.5m$6.3m$10.3m
Net income$17.3m$2.7m$24.5m$2.1m
Adjusted EBITDA (non-GAAP)$16.1m$7.4m$42.2m$16.1m
Adjusted EBITDA margin (non-GAAP)13.0%7.7%11.4%6.3%

Q3 sales increased 28.1%; management attributed the increase to 24.4% higher product volume overall, 2.8% from price and mix, and 0.8% from foreign exchange. Within volume, organic sales fell 7.7%, while recently acquired proprietary brands contributed 32.1% growth. Nine-month sales rose 44.8%, with volume up 39.3% (organic sales up 23.6% and acquired brands contributing 15.7%), price and mix up 3.7%, and foreign exchange up 1.9%.

Gross margin improved substantially, primarily on a richer mix of higher-margin proprietary and preferred brands; nine-month results also benefited from improved first-half labor efficiencies. These gains more than offset higher freight/import and labor costs. Q3 operating loss reflected SG&A growth, including acquisition-related and integration costs, public-company and growth-related expenses, and warrant solicitation fees. The reported Q3 and nine-month net income included income-tax benefits of $19.8m and $19.0m, respectively, primarily from releasing part of the deferred-tax valuation allowance following the H&G acquisition. Thus, net income growth should be viewed in light of this tax benefit.

Cash flow, liquidity and debt

  • For the first nine months, operating cash flow was negative $17.5m, versus negative $7.8m a year earlier. Management cited a $39.8m increase in working capital, including substantial inventory growth.
  • Investing cash outflow was $419.4m, principally $415.9m for four acquisitions; financing cash inflow was $374.4m, including $309.8m net proceeds from a May follow-on offering and $56.8m from warrant exercises.
  • Cash, cash equivalents and restricted cash totaled $14.5m at September 30, 2021, down from $77.0m at December 31, 2020. Current assets were $222.5m and current liabilities were $118.6m.
  • Debt at September 30 was $27.7m, including $26.5m drawn on the JPMorgan revolver. The $100m revolver had approximately $78.6m of borrowing availability, including $51.8m unused; the company reported compliance with its covenants, including a 1.1x minimum fixed-charge coverage ratio.
  • After quarter-end, the company borrowed $125m under a senior secured term loan, receiving estimated net proceeds of $119.2m. It matures in October 2028, carries interest at LIBOR plus 5.50% (subject to a 1.0% floor) or an alternative base rate plus 4.50%, and was intended to fund the subsequent IGE acquisition and general corporate purposes.

Material changes, outlook and risks

  • During the period, Hydrofarm acquired Heavy 16, the House & Garden entities, Aurora and Greenstar, broadening proprietary nutrients, fertilizers and grow-media brands. The acquisitions added $297.5m of goodwill and contributed an estimated $31m of Q3 sales and $9m of Q3 net income since acquisition dates; management cautioned these contribution estimates are approximate. Purchase-price allocations remained provisional.
  • On November 1, 2021, the company acquired the IGE entities, a manufacturer of horticulture benches, racking and LED lighting systems, for approximately $58m, subject to customary adjustments. This is a subsequent event, not included in September 30 results.
  • No specific revenue or earnings guidance is provided in the filing. Management described the business as resilient during COVID-19 but reported supply-chain interruptions and higher shipping costs; it warned renewed factory closures or cost increases could affect inventory availability and margins. Management also cited short-term oversupply pressuring cannabis-growing activity, particularly in California and Canada.
  • Other relevant exposures include acquisition integration and execution, contingent acquisition consideration, competition and customer/grower conditions, foreign-exchange movements, and substantial new warehouse lease commitments. Executed but not-yet-commenced leases had $53.8m of future minimum payments disclosed; additional warehouse leases were signed after quarter-end.
  • Management concluded disclosure controls were not effective as of September 30 because previously disclosed material weaknesses in internal control over financial reporting had not been remediated. Remediation efforts were ongoing; the company warned it could not assure they would be sufficient.

Most important facts for investors to verify

  • Whether organic demand stabilizes after Q3’s 7.7% decline, and how much future growth depends on acquired brands and acquisitions.
  • Whether the improved gross margin persists as freight, import, labor and supply-chain costs evolve.
  • How much reported earnings reflect the nonrecurring tax benefit, acquisition costs, and other Adjusted EBITDA exclusions; compare non-GAAP results with GAAP cash generation.
  • Whether working-capital investment, particularly inventory, converts into sales and operating cash flow, given low period-end cash after acquisitions.
  • Integration results and final purchase accounting for the acquisitions, contingent consideration, and the financing and performance of the post-quarter IGE acquisition.
  • Progress in remediating material weaknesses and continued compliance with debt covenants and lease obligations.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.